Synthesis and antiviral activity of 2'-substituted 9-[2-(phosphonomethoxy)ethyl]guanine analogues. 1993

K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Wallingford, Connecticut 06492-7660.

A series of 2'-substituted derivatives of 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG, 1) have been synthesized and evaluated in vitro for anti-human immunodeficiency virus (HIV) activity in the XTT assay and for anti-herpes activity in the plaque reduction assay. It has been observed that the anti-HIV activity of these derivatives depends on the size and the nature of the substituent as well as the chirality at the 2'-position of PMEG. In addition, these compounds generally demonstrated greater activity against HIV than herpes viruses. The most interesting analogues which emerged from these studies are (R)-2'-(azidomethyl)-PMEG [(R)-5] and (R)-2'-vinyl-PMEG [(R)-11]. The former showed anti-HIV activity with an IC50 of 5 microM and a cytotoxicity (CC50) greater than 1.4 mM in CEM cells. The latter has an IC50 of 13 microM for anti-HIV activity and a CC50 of greater than 1.6 mM. Furthermore, we have demonstrated that replacement of the guanine base of these 2'-substituted PMEG analogues with cytosine drastically reduces anti-HIV and anti-herpes activity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D006147 Guanine
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
January 2005, Nucleosides, nucleotides & nucleic acids,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
June 1990, Journal of medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
December 2006, Journal of medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
August 1996, Journal of medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
December 2016, Journal of medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
April 2011, Bioorganic & medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
November 2003, Journal of medicinal chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
December 2004, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
March 2011, Molecular vision,
K L Yu, and J J Bronson, and H Yang, and A Patick, and M Alam, and V Brankovan, and R Datema, and M J Hitchcock, and J C Martin
January 2005, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!